Current and emerging concepts in non-invasive and minimally invasive management of spine metastasis

Cancer Treatment Reviews

Volumn 39, Issue 2, 2013, Pages 142-152

  Bhatt, Aashish D ^a   Schuler, John C ^a   Boakye, Maxwell ^a   Woo, Shiao Y ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Kyphoplasty; Radiation therapy (RT); Spinal cord compression (SCC); Spine metastasis (SM); Stereotactic radiosurgery (SRS); Vertebroplasty

Indexed keywords

DEXAMETHASONE;

ANALGESIA; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DECOMPRESSIVE LAMINECTOMY; DISEASE COURSE; HUMAN; KYPHOPLASTY; LAMINECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERCUTANEOUS VERTEBROPLASTY; QUALITY OF LIFE; RADIOSURGERY; REVIEW; SCORING SYSTEM; SPINAL CORD COMPRESSION; SPINE METASTASIS; STEREOTACTIC BODY RADIATION THERAPY; SURGICAL APPROACH; TREATMENT INDICATION;

HUMANS; KYPHOPLASTY; LAMINECTOMY; QUALITY OF LIFE; SPINAL CORD COMPRESSION; SPINAL NEOPLASMS; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 84869496381     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2012.08.002     Document Type: Review

References (144)

1. Bailar J.C., Gornik H.L. Cancer undefeated. N Engl J Med 1997, 336(22):1569-1574.
2. American Cancer Society. Cancer facts & figures 2010. Atlanta: American Cancer Society; 2010.
3. Witham T.F., Khavkin Y.A., Gallia G.L., Wolinsky J.P., Gokaslan Z.L. Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nat Clin Pract Neurol 2006, 2(2):87-94. [quiz 116].
4. Hatrick N.C., Lucas J.D., Timothy A.R., Smith M.A. The surgical treatment of metastatic disease of the spine. Radiother Oncol 2000, 56(3):335-339.
5. Ortiz Gomez J.A. The incidence of vertebral body metastases. Int Orthop 1995, 19(5):309-311.
6. Brihaye J., Ectors P., Lemort M., Van Houtte P. The management of spinal epidural metastases. Adv Tech Stand Neurosurg 1988, 16:121-176.
7. van der Linden Y.M., Dijkstra S.P., Vonk E.J., Marijnen C.A., Leer J.W. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 2005, 103(2):320-328.
8. Maranzano E., Bellavita R., Rossi R., et al. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol 2005, 23(15):3358-3365.
9. Maranzano E., Latini P. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiat Oncol Biol Phys 1995, 32(4):959-967.
10. Gerszten P.C., Mendel E., Yamada Y. Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes?. Spine (Phila Pa 1976) 2009, 34(22 Suppl.):S78-92.
11. Tokuhashi Y., Matsuzaki H., Oda H., Oshima M., Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 2005, 30(19):2186-2191.
12. Perrin R.G., Laxton A.W. Metastatic spine disease: epidemiology, pathophysiology, and evaluation of patients. Neurosurg Clin N Am 2004, 15(4):365-373.
13. Klimo P., Thompson C.J., Kestle J.R., Schmidt M.H. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro Oncol 2005, 7(1):64-76.
14. Jacobs W.B., Perrin R.G. Evaluation and treatment of spinal metastases: an overview. Neurosurg Focus 2001, 11(6):e10.
15. Schiff D., O'Neill B.P., Suman V.J. Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach. Neurology 1997, 49(2):452-456.
16. Constans J.P., de Divitiis E., Donzelli R., Spaziante R., Meder J.F., Haye C. Spinal metastases with neurological manifestations. Review of 600 cases. J Neurosurg 1983, 59(1):111-118.
17. Arguello F., Baggs R.B., Duerst R.E., Johnstone L., McQueen K., Frantz C.N. Pathogenesis of vertebral metastasis and epidural spinal cord compression. Cancer 1990, 65(1):98-106.
18. Batson O.V. The function of the vertebral veins and their role in the spread of metastases. Ann Surg 1940, 112(1):138-149.
19. Gilbert R.W., Kim J.H., Posner J.B. Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 1978, 3(1):40-51.
20. Rose P.S., Buchowski J.M. Metastatic disease in the thoracic and lumbar spine: evaluation and management. J Am Acad Orthop Surg 2011, 19(1):37-48.
21. Perrin R.G. Metastatic tumors of the axial spine. Curr Opin Oncol 1992, 4(3):525-532.
22. Edelstyn G.A., Gillespie P.J., Grebbell F.S. The radiological demonstration of osseous metastases. Experimental observations. Clin Radiol 1967, 18(2):158-162.
23. Kienstra G.E., Terwee C.B., Dekker F.W., et al. Prediction of spinal epidural metastases. Arch Neurol 2000, 57(5):690-695.
24. Ramsdell J.W., Peters R.M., Taylor A.T., Alazraki N.P., Tisi G.M. Multiorgan scans for staging lung cancer. correlation with clinical evaluation. J Thorac Cardiovasc Surg 1977, 73(5):653-659.
25. Buhmann Kirchhoff S., Becker C., Duerr H.R., Reiser M., Baur-Melnyk A. Detection of osseous metastases of the spine: comparison of high resolution multi-detector-CT with MRI. Eur J Radiol 2009, 69(3):567-573.
26. Jung H.S., Jee W.H., McCauley T.R., Ha K.Y., Choi K.H. Discrimination of metastatic from acute osteoporotic compression spinal fractures with MR imaging. Radiographics 2003, 23(1):179-187.
27. Husband D.J., Grant K.A., Romaniuk C.S. MRI in the diagnosis and treatment of suspected malignant spinal cord compression. Br J Radiol 2001, 74(877):15-23.
28. Rodichok L.D., Ruckdeschel J.C., Harper G.R., et al. Early detection and treatment of spinal epidural metastases: the role of myelography. Ann Neurol 1986, 20(6):696-702.
29. O'Rourke T., George C.B., Redmond J., et al. Spinal computed tomography and computed tomographic metrizamide myelography in the early diagnosis of metastatic disease. J Clin Oncol 1986, 4(4):576-583.
30. Eary J.F. Nuclear medicine in cancer diagnosis. Lancet 1999, 354(9181):853-857.
31. Peterson J.J., Kransdorf M.J., O'Connor M.I. Diagnosis of occult bone metastases: positron emission tomography. Clin Orthop Relat Res 2003, (415 Suppl.):S120-S128.
32. Gayed I., Vu T., Johnson M., Macapinlac H., Podoloff D. Comparison of bone and 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in the evaluation of bony metastases in lung cancer. Mol Imaging Biol 2003, 5(1):26-31.
33. Cleeland C.S., Ryan K.M. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994, 23(2):129-138.
34. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5(6):649-655.
35. Bauer H., Tomita K., Kawahara N., Abdel-Wanis M.E., Murakami H. Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 2002, 27(10):1124-1126.
36. Tokuhashi Y., Matsuzaki H., Toriyama S., Kawano H., Ohsaka S. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 1990, 15(11):1110-1113.
37. Tomita K., Kawahara N., Kobayashi T., Yoshida A., Murakami H., Akamaru T. Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 2001, 26(3):298-306.
38. Kim R.Y., Spencer S.A., Meredith R.F., et al. Extradural spinal cord compression: analysis of factors determining functional prognosis - prospective study. Radiology 1990, 176(1):279-282.
39. Yalamanchili M., Lesser G.J. Malignant spinal cord compression. Curr Treat Options Oncol 2003, 4(6):509-516.
40. Frankel H.L., Hancock D.O., Hyslop G., et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia I. Paraplegia 1969, 7(3):179-192.
41. Heary R.F., Bono C.M. Metastatic spinal tumors. Neurosurg Focus 2001, 11(6):e1.
42. Sciubba D.M., Gokaslan Z.L. Diagnosis and management of metastatic spine disease. Surg Oncol 2006, 15(3):141-151.
43. Dy S.M., Asch S.M., Naeim A., Sanati H., Walling A., Lorenz K.A. Evidence-based standards for cancer pain management. J Clin Oncol 2008, 26(23):3879-3885.
44. Conti P.D., Atallah A.N., Arruda H., Soares B.G., El Dib R.P., Wilt T.J. Intermittent versus continuous androgen suppression for prostatic cancer. Cochrane Database Syst Rev 2007, 4:CD005009.
45. Morandi P., Rouzier R., Altundag K., Buzdar A.U., Theriault R.L., Hortobagyi G. The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the MD Anderson Cancer Center evidence-based approach. Cancer 2004, 101(7):1482-1489.
46. Roodman G.D. Mechanisms of bone metastasis. N Engl J Med 2004, 350(16):1655-1664.
47. Stopeck A.T., Lipton A., Body J.J., et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 2010, 28(35):5132-5139.
48. Henry D.H., Costa L., Goldwasser F., et al. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 2011, 29(9):1125-1132.
49. Harrington K.D. Metastatic disease of the spine. J Bone Joint Surg Am 1986, 68(7):1110-1115.
50. Leithner A., Radl R., Gruber G., et al. Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J 2008, 17(11):1488-1495.
51. Bilsky M., Smith M. Surgical approach to epidural spinal cord compression. Hematol Oncol Clin North Am 2006, 20(6):1307-1317.
52. Walker M.P., Yaszemski M.J., Kim C.W., Talac R., Currier B.L. Metastatic disease of the spine: evaluation and treatment. Clin Orthop Relat Res 2003, (415 Suppl.):S165-175.
53. White B.D., Stirling A.J., Paterson E., Asquith-Coe K., Melder A. Diagnosis and management of patients at risk of or with metastatic spinal cord compression: summary of NICE guidance. BMJ 2008, 337:a2538.
54. Nathan S.S., Healey J.H., Mellano D., et al. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol 2005, 23(25):6072-6082.
55. Simmons E.D., Zheng Y. Vertebral tumors: surgical versus nonsurgical treatment. Clin Orthop Relat Res 2006, 443:233-247.
56. Quraishi N.A., Gokaslan Z.L., Boriani S. The surgical management of metastatic epidural compression of the spinal cord. J Bone Joint Surg Br 2010, 92(8):1054-1060.
57. Bartels R.H., van der Linden Y.M., van der Graaf W.T. Spinal extradural metastasis: review of current treatment options. CA Cancer J Clin 2008, 58(4):245-259.
58. Fisher C.G., DiPaola C.P., Ryken T.C., et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976) 2010, 35(22):E1221-E1229.
59. Fourney D.R., Frangou E.M., Ryken T.C., et al. Spinal instability neoplastic score: an analysis of reliability and validity from the Spine Oncology Study Group. J Clin Oncol 2011, 29(22):3072-3077.
60. Cybulski G.R. Methods of surgical stabilization for metastatic disease of the spine. Neurosurgery 1989, 25(2):240-252.
61. Young R.F., Post E.M., King G.A. Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg 1980, 53(6):741-748.
62. Sciubba D.M., Petteys R.J., Dekutoski M.B., et al. Diagnosis and management of metastatic spine disease. J Neurosurg Spine 2010, 13(1):94-108.
63. Patchell R.A., Tibbs P.A., Regine W.F., et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005, 366(9486):643-648.
64. Pflugmacher R., Beth P., Schroeder R.J., Schaser K.D., Melcher I. Balloon kyphoplasty for the treatment of pathological fractures in the thoracic and lumbar spine caused by metastasis: one-year follow-up. Acta Radiol 2007, 48(1):89-95.
65. Gerszten P.C., Monaco E.A. Complete percutaneous treatment of vertebral body tumors causing spinal canal compromise using a transpedicular cavitation, cement augmentation, and radiosurgical technique. Neurosurg Focus 2009, 27(6):E9.
66. Dalbayrak S., Onen M.R., Yilmaz M., Naderi S. Clinical and radiographic results of balloon kyphoplasty for treatment of vertebral body metastases and multiple myelomas. J Clin Neurosci 2010, 17(2):219-224.
67. Mendel E., Bourekas E., Gerszten P., Golan J.D. Percutaneous techniques in the treatment of spine tumors: what are the diagnostic and therapeutic indications and outcomes?. Spine (Phila Pa 1976) 2009, 34(22 Suppl.):S93-100.
68. Tancioni F., Lorenzetti M.A., Navarria P., et al. Percutaneous vertebral augmentation in metastatic disease: state of the art. J Support Oncol 2011, 9(1):4-10.
69. Deramond H., Depriester C., Toussaint P. Vertebroplasty and percutaneous interventional radiology in bone metastases: techniques, indications, contra-indications. Bull Cancer Radiother 1996, 83(4):277-282.
70. McKiernan F., Faciszewski T., Jensen R. Quality of life following vertebroplasty. J Bone Joint Surg Am 2004, 86-A(12):2600-2606.
71. Cotten A., Dewatre F., Cortet B., et al. Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Radiology 1996, 200(2):525-530.
72. Weill A., Chiras J., Simon J.M., Rose M., Sola-Martinez T., Enkaoua E. Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology 1996, 199(1):241-247.
73. Cortet B., Cotten A., Boutry N., et al. Percutaneous vertebroplasty in patients with osteolytic metastases or multiple myeloma. Rev Rhum Engl Ed 1997, 64(3):177-183.
74. Fourney D.R., Schomer D.F., Nader R., et al. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg 2003, 98(1 Suppl):21-30.
75. Martin J.B., Wetzel S.G., Seium Y., et al. Percutaneous vertebroplasty in metastatic disease: transpedicular access and treatment of lysed pedicles-initial experience. Radiology 2003, 229(2):593-597.
76. Alvarez L., Perez-Higueras A., Quinones D., Calvo E., Rossi R.E. Vertebroplasty in the treatment of vertebral tumors: postprocedural outcome and quality of life. Eur Spine J 2003, 12(4):356-360.
77. Shimony J.S., Gilula L.A., Zeller A.J., Brown D.B. Percutaneous vertebroplasty for malignant compression fractures with epidural involvement. Radiology 2004, 232(3):846-853.
78. Bartolozzi B., Nozzoli C., Pandolfo C., et al. Percutaneous vertebroplasty and kyphoplasty in patients with multiple myeloma. Eur J Haematol 2006, 76(2):180-181.
79. Cardoso E.R., Ashamalla H., Weng L., et al. Percutaneous tumor curettage and interstitial delivery of samarium-153 coupled with kyphoplasty for treatment of vertebral metastases. J Neurosurg Spine 2009, 10(4):336-342.
80. Sandri A., Carbognin G., Regis D., et al. Combined radiofrequency and kyphoplasty in painful osteolytic metastases to vertebral bodies. Radiol Med 2010, 115(2):261-271.
81. Cheung G., Chow E., Holden L., et al. Percutaneous vertebroplasty in patients with intractable pain from osteoporotic or metastatic fractures: a prospective study using quality-of-life assessment. Can Assoc Radiol J 2006, 57(1):13-21.
82. Bruera E., Kuehn N., Miller M.J., Selmser P., Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991, 7(2):6-9.
83. Chang V.T., Hwang S.S., Feuerman M. Validation of the Edmonton symptom assessment scale. Cancer 2000, 88(9):2164-2171.
84. Street J., Lenehan B., Berven S., Fisher C. Introducing a new health-related quality of life outcome tool for metastatic disease of the spine: content validation using the International Classification of Functioning, Disability, and Health; on behalf of the Spine Oncology Study Group. Spine (Phila Pa 1976) 2010, 35(14):1377-1386.
85. Gu Q., Wang D., Cui C., Gao Y., Xia G., Cui X. Effects of radiation on wound healing. J Environ Pathol Toxicol Oncol 1998, 17(2):117-123.
86. Itshayek E., Yamada J., Bilsky M., et al. Timing of surgery and radiotherapy in the management of metastatic spine disease: a systematic review. Int J Oncol 2010, 36(3):533-544.
87. Ghogawala Z., Mansfield F.L., Borges L.F. Spinal radiation before surgical decompression adversely affects outcomes of surgery for symptomatic metastatic spinal cord compression. Spine (Phila Pa 1976) 2001, 26(7):818-824.
88. Townsend P.W., Rosenthal H.G., Smalley S.R., Cozad S.C., Hassanein R.E. Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. J Clin Oncol 1994, 12(11):2345-2350.
89. Rock J.P., Ryu S., Shukairy M.S., et al. Postoperative radiosurgery for malignant spinal tumors. Neurosurgery 2006, 58(5):891-898. [discussion 891-898].
90. Moulding H.D., Elder J.B., Lis E., et al. Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases. J Neurosurg Spine 2010, 13(1):87-93.
91. Faul C.M., Flickinger J.C. The use of radiation in the management of spinal metastases. JNeurooncol 1995, 23(2):149-161.
92. Rades D., Stalpers L.J., Veninga T., et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005, 23(15):3366-3375.
93. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol 1999;52(2):111-21.
94. Steenland E., Leer J.W., van Houwelingen H., et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999, 52(2):101-109.
95. Tong D., Gillick L., Hendrickson F.R. The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group. Cancer 1982, 50(5):893-899.
96. Wu J.S., Wong R., Johnston M., Bezjak A., Whelan T. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003, 55(3):594-605.
97. Wu J.S., Wong R.K., Lloyd N.S., Johnston M., Bezjak A., Whelan T. Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases - an evidence-based practice guideline. BMC Cancer 2004, 4:71.
98. Andrews D.W., Bednarz G., Evans J.J., Downes B. A review of 3 current radiosurgery systems. Surg Neurol 2006, 66(6):559-564.
99. Niranjan A., Maitz A.H., Lunsford A., et al. Radiosurgery techniques and current devices. Prog Neurol Surg 2007, 20:50-67.
100. Ryu S., Fang Yin F., Rock J., et al. Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer 2003, 97(8):2013-2018.
101. Wang Z., Nelson J.W., Yoo S., et al. Refinement of treatment setup and target localization accuracy using three-dimensional cone-beam computed tomography for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2009, 73(2):571-577.
102. Ho A.K., Fu D., Cotrutz C., et al. A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking. Neurosurgery 2007, 60(2 Suppl 1). ONS147-156 [discussion ONS156].
103. Flickinger J.C., Kondziolka D., Lunsford L.D. Radiobiological analysis of tissue responses following radiosurgery. Technol Cancer Res Treat 2003, 2(2):87-92.
104. Gerszten P.C., Lunsford L.D., Rutigliano M.J., Kondziolka D., Flickinger J.C., Martinez A.J. Single-stage stereotactic diagnosis and radiosurgery: feasibility and cost implications. J Image Guid Surg 1995, 1(3):141-150.
105. Rutigliano M.J., Lunsford L.D., Kondziolka D., Strauss M.J., Khanna V., Green M. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery 1995, 37(3):445-453. [discussion 453-445].
106. Sheehan J.P., Shaffrey C.I., Schlesinger D., Williams B.J., Arlet V., Larner J. Radiosurgery in the treatment of spinal metastases: tumor control, survival, and quality of life after helical tomotherapy. Neurosurgery 2009, 65(6):1052-1061. [discussion 1061-1052].
107. Chao S.T., Koyfman S.A., Woody N., et al. Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases. Int J Radiat Oncol Biol Phys 2011, 82(5):1738-1743.
108. Ryu S., Rock J., Rosenblum M., Kim J.H. Patterns of failure after single-dose radiosurgery for spinal metastasis. J Neurosurg 2004, 101(Suppl 3):402-405.
109. Chang E.L., Shiu A.S., Mendel E., et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 2007, 7(2):151-160.
110. Gerszten P.C., Burton S.A., Ozhasoglu C., Welch W.C. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 2007, 32(2):193-199.
111. Yamada Y., Bilsky M.H., Lovelock D.M., et al. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 2008, 71(2):484-490.
112. Gerszten P.C., Germanwala A., Burton S.A., Welch W.C., Ozhasoglu C., Vogel W.J. Combination kyphoplasty and spinal radiosurgery: a new treatment paradigm for pathological fractures. J Neurosurg Spine 2005, 3(4):296-301.
113. De Salles A.A., Pedroso A.G., Medin P., et al. Spinal lesions treated with Novalis shaped beam intensity-modulated radiosurgery and stereotactic radiotherapy. J Neurosurg 2004, 101(Suppl 3):435-440.
114. Ryu S., Jin J.Y., Jin R., et al. Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery. Cancer 2007, 109(3):628-636.
115. Sahgal A., Ma L., Gibbs I., et al. Spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010, 77(2):548-553.
116. Garg A.K., Wang X.S., Shiu A.S., et al. Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: The University of Texas MD Anderson Cancer Center Experience. Cancer 2011, 117(15):3509-3516.
117. Ang K.K., Price R.E., Stephens L.C., et al. The tolerance of primate spinal cord to re-irradiation. Int J Radiat Oncol Biol Phys 1993, 25(3):459-464.
118. Ryu S., Gorty S., Kazee A.M., et al. 'Full dose' reirradiation of human cervical spinal cord. Am J Clin Oncol 2000, 23(1):29-31.
119. Sahgal A., Ma L., Weinberg V., et al. Reirradiation HUMAN Spinal Cord Tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010, 77(2):548-553.
120. Reagan T.J., Thomas J.E., Colby M.Y. Chronic progressive radiation myelopathy. Its clinical aspects and differential diagnosis. JAMA 1968, 203(2):106-110.
121. Powers B.E., Thames H.D., Gillette S.M., Smith C., Beck E.R., Gillette E.L. Volume effects in the irradiated canine spinal cord: do they exist when the probability of injury is low?. Radiother Oncol 1998, 46(3):297-306.
122. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21(1):109-122.
123. Gibbs I.C., Patil C., Gerszten P.C., Adler J.R., Burton S.A. Delayed radiation-induced myelopathy after spinal radiosurgery. Neurosurgery 2009, 64(2 Suppl):A67-72.
124. Degen J.W., Gagnon G.J., Voyadzis J.M., et al. CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life. J Neurosurg Spine 2005, 2(5):540-549.
125. Gibbs I.C., Kamnerdsupaphon P., Ryu M.R., et al. Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol 2007, 82(2):185-190.
126. Sahgal A., Ames C., Chou D., et al. Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. Int J Radiat Oncol Biol Phys 2009, 74(3):723-731.
127. Nelson J.W., Yoo D.S., Sampson J.H., et al. Stereotactic body radiotherapy for lesions of the spine and paraspinal regions. Int J Radiat Oncol Biol Phys 2009, 73(5):1369-1375.
128. Haley M.L., Gerszten P.C., Heron D.E., Chang Y.F., Atteberry D.S., Burton S.A. Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis. J Neurosurg Spine 2011, 14(4):537-542.
129. Bach F., Larsen B.H., Rohde K., et al. Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression. Acta Neurochir (Wien) 1990, 107(1-2):37-43.
130. Levack P., Graham J., Collie D., et al. Don't wait for a sensory level-listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression. Clin Oncol (R Coll Radiol) 2002, 14(6):472-480.
131. Helweg-Larsen S., Sorensen P.S. Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients. Eur J Cancer 1994, 30A(3):396-398.
132. Schiff D. Spinal cord compression. Neurol Clin 2003, 21(1). 67-86, viii.
133. Sorensen S., Helweg-Larsen S., Mouridsen H., Hansen H.H. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur J Cancer 1994, 30A(1):22-27.
134. Helweg-Larsen S. Clinical outcome in metastatic spinal cord compression. A prospective study of 153 patients. Acta Neurol Scand 1996, 94(4):269-275.
135. Ibrahim A., Crockard A., Antonietti P., et al. Does spinal surgery improve the quality of life for those with extradural (spinal) osseous metastases? An international multicenter prospective observational study of 223 patients. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2007. J Neurosurg Spine 2008, 8(3):271-278.
136. Maranzano E., Trippa F., Casale M., et al. 8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiother Oncol 2009, 93(2):174-179.
137. Rades D., Lange M., Veninga T., et al. Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression. Int J Radiat Oncol Biol Phys 2009, 73(1):228-234.
138. Jin R., Rock J., Jin J.Y., et al. Single fraction spine radiosurgery for myeloma epidural spinal cord compression. J Exp Ther Oncol 2009, 8(1):35-41.
139. Saito T., Kondo T., Hozumi T., Karasawa K., Seichi A., Nakamura K. Results of posterior surgery with intraoperative radiotherapy for spinal metastases. Eur Spine J 2006, 15(2):216-222.
140. Kondo T., Hozumi T., Goto T., Seichi A., Nakamura K. Intraoperative radiotherapy combined with posterior decompression and stabilization for non-ambulant paralytic patients due to spinal metastasis. Spine (Phila Pa 1976) 2008, 33(17):1898-1904.
141. Rades D., Fehlauer F., Schulte R., et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 2006, 24(21):3388-3393.
142. Rades D., Heidenreich F., Karstens J.H. Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2002, 53(4):975-979.
143. Rades D., Blach M., Bremer M., Wildfang I., Karstens J.H., Heidenreich F. Prognostic significance of the time of developing motor deficits before radiation therapy in metastatic spinal cord compression: one-year results of a prospective trial. Int J Radiat Oncol Biol Phys 2000, 48(5):1403-1408.
144. Zaidat O.O., Ruff R.L. Treatment of spinal epidural metastasis improves patient survival and functional state. Neurology 2002, 58(9):1360-1366.